[
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin iv",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin iv",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin oral (uncomplicated UTI only)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin oral (uncomplicated UTI only)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin-sulbactam iv",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 82.0,
    "breakpoint_R": 82.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin-sulbactam iv",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin-sulbactam oral (uncomplicated UTI only)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 82.0,
    "breakpoint_R": 82.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ampicillin-sulbactam oral (uncomplicated UTI only)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin iv",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin oral (infections originating from the urinary tract)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin oral (uncomplicated UTI only)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin oral (other indications)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0013,
    "breakpoint_R": 83.0,
    "unit": "mg/L",
    "indication": "other indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid iv",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 84.0,
    "breakpoint_R": 84.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid iv",
    "ab": "AMX",
    "category": null,
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid oral (infections originating from the urinary tract)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0014,
    "breakpoint_R": 84.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid oral (infections originating from the urinary tract)",
    "ab": "AMX",
    "category": null,
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid oral (uncomplicated UTI only)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 324.0,
    "breakpoint_R": 324.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid oral (uncomplicated UTI only)",
    "ab": "AMX",
    "category": null,
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amoxicillin-clavulanic acid oral (other indications)",
    "ab": "AMX",
    "category": null,
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "other indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Piperacillin",
    "ab": "PIP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Piperacillin",
    "ab": "PIP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 85.0,
    "breakpoint_R": 85.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ticarcillin-clavulanic acid",
    "ab": "TCC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 84.0,
    "breakpoint_R": 164.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ticarcillin-clavulanic acid",
    "ab": "TCC",
    "category": null,
    "method": "DISK",
    "disk_dose": "75-10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Temocillin (infections originating from the urinary tract), E. coli, Klebsiella spp. (except K. aerogenes) and P. mirabilis",
    "ab": "TEM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Temocillin (infections originating from the urinary tract), E. coli, Klebsiella spp. (except K. aerogenes) and P. mirabilis",
    "ab": "TEM",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Mecillinam oral (pivmecillinam) (uncomplicated UTI only), E. coli, Citrobacter spp., Klebsiella\u00a0spp.,\u00a0Raoultella spp., Enterobacter\u00a0spp. and P. mirabilis",
    "ab": "MEC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 86.0,
    "breakpoint_R": 86.0,
    "unit": "mg/L",
    "indication": "pivmecillinam",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Mecillinam oral (pivmecillinam) (uncomplicated UTI only), E. coli, Citrobacter spp., Klebsiella\u00a0spp.,\u00a0Raoultella spp., Enterobacter\u00a0spp. and P. mirabilis",
    "ab": "MEC",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "pivmecillinam",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefadroxil (uncomplicated UTI only)",
    "ab": "CFR",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefadroxil (uncomplicated UTI only)",
    "ab": "CFR",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefalexin (uncomplicated UTI only)",
    "ab": "LEX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefalexin (uncomplicated UTI only)",
    "ab": "LEX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefazolin (infections originating from the urinary tract), E. coli and Klebsiella spp. (except K. aerogenes)",
    "ab": "CZO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.0012,
    "breakpoint_R": 42.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefazolin (infections originating from the urinary tract), E. coli and Klebsiella spp. (except K. aerogenes)",
    "ab": "CZO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefepime-enmetazobactam",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 43.0,
    "breakpoint_R": 43.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefepime-enmetazobactam",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30-20",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefiderocol",
    "ab": "FDC",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefiderocol",
    "ab": "FDC",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefixime (uncomplicated UTI only)",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefixime (uncomplicated UTI only)",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefotaxime (indications other than meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefotaxime (indications other than meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefotaxime (meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefotaxime (meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefoxitin (screen only)",
    "ab": "FOX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefpodoxime \n(uncomplicated UTI only)",
    "ab": "CPD",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefpodoxime \n(uncomplicated UTI only)",
    "ab": "CPD",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftaroline",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftaroline",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftazidime-avibactam",
    "ab": "CZA",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 86.0,
    "breakpoint_R": 86.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftazidime-avibactam",
    "ab": "CZA",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10-4",
    "breakpoint_S": 13.0,
    "breakpoint_R": 13.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftibuten (infections originating from the urinary tract)",
    "ab": "CTB",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftibuten (infections originating from the urinary tract)",
    "ab": "CTB",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftobiprole",
    "ab": "BPR",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftobiprole",
    "ab": "BPR",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftolozane-tazobactam",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftolozane-tazobactam",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30-10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftriaxone (indications other than meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftriaxone (indications other than meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftriaxone (meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ceftriaxone (meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefuroxime iv, E. coli, Klebsiella spp. (except K. aerogenes), Raoultella spp. and P. mirabilis",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "except k. aerogenes",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefuroxime iv, E. coli, Klebsiella spp. (except K. aerogenes), Raoultella spp. and P. mirabilis",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "except k. aerogenes",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefuroxime oral (uncomplicated UTI only), E. coli, Klebsiella spp. (except K. aerogenes), Raoultella spp. and P. mirabilis",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Cefuroxime oral (uncomplicated UTI only), E. coli, Klebsiella spp. (except K. aerogenes), Raoultella spp. and P. mirabilis",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem, Enterobacterales except Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem, Enterobacterales except Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem2, Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem2, Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem-relebactam, Enterobacterales except Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Imipenem-relebactam, Enterobacterales except Morganellaceae",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10-25",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem-vaborbactam",
    "ab": "MVB",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 84.0,
    "breakpoint_R": 84.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Meropenem-vaborbactam",
    "ab": "MVB",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 26.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Aztreonam-avibactam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 42.0,
    "breakpoint_R": 42.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Aztreonam-avibactam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "30-20",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ciprofloxacin, Salmonella spp.",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ciprofloxacin (indications other than meningitis)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ciprofloxacin (indications other than meningitis)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 25.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ciprofloxacin (meningitis)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Pefloxacin (screen only)",
    "ab": "PEF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Delafloxacin, E. coli",
    "ab": "DEL",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Moxifloxacin, Enterobacterales except Morganella morganii, Proteus spp. and Serratia spp.",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Moxifloxacin, Enterobacterales except Morganella morganii, Proteus spp. and Serratia spp.",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Norfloxacin (uncomplicated UTI only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Norfloxacin (uncomplicated UTI only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 24.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 81.0,
    "breakpoint_R": 81.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Gentamicin (systemic infections)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Gentamicin (systemic infections)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Gentamicin (infections originating from the urinary tract)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Gentamicin (infections originating from the urinary tract)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Eravacycline, E. coli",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Eravacycline, E. coli",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "20",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Tigecycline, E. coli and C. koseri",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Colistin",
    "ab": "COL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Fosfomycin iv (infections originating from the urinary tract), E. coli",
    "ab": "FOS",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 84.0,
    "breakpoint_R": 84.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Fosfomycin iv (infections originating from the urinary tract), E. coli",
    "ab": "FOS",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "200C",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Fosfomycin oral \n(uncomplicated UTI only), E. coli",
    "ab": "FOS",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 84.0,
    "breakpoint_R": 84.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Fosfomycin oral \n(uncomplicated UTI only), E. coli",
    "ab": "FOS",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "200C",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Gepotidacin (uncomplicated UTI only), \nE. coli",
    "ab": "GEP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nE. coli",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 64.0,
    "breakpoint_R": 64.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nE. coli",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "100",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Nitroxoline (uncomplicated UTI only), \nE. coli",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Nitroxoline (uncomplicated UTI only), \nE. coli",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim (uncomplicated UTI only), E. coli and Klebsiella spp. (except K. aerogenes)",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim (uncomplicated UTI only), E. coli and Klebsiella spp. (except K. aerogenes)",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim-sulfamethoxazole8, \nEnterobacterales except Serratia spp.",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim-sulfamethoxazole8, \nEnterobacterales except Serratia spp.",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim-sulfamethoxazole8, \nSerratia spp.",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterobacterales",
    "antimicrobial": "Trimethoprim-sulfamethoxazole8, \nSerratia spp.",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 50.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Piperacillin",
    "ab": "PIP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Piperacillin",
    "ab": "PIP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0011,
    "breakpoint_R": 161.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ticarcillin-clavulanic acid",
    "ab": "TCC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0012,
    "breakpoint_R": 162.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ticarcillin-clavulanic acid",
    "ab": "TCC",
    "category": null,
    "method": "DISK",
    "disk_dose": "75-10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Cefiderocol, P. aeruginosa",
    "ab": "FDC",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Cefiderocol, P. aeruginosa",
    "ab": "FDC",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftazidime-avibactam, P. aeruginosa",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 83.0,
    "breakpoint_R": 83.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftazidime-avibactam, P. aeruginosa",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10-4",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftolozane-tazobactam4, P. aeruginosa",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 45.0,
    "breakpoint_R": 45.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ceftolozane-tazobactam4, P. aeruginosa",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30-10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Imipenem-relebactam, P. aeruginosa",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Imipenem-relebactam, P. aeruginosa",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10-25",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (indications other than meningitis), P. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (indications other than meningitis), P. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (indications other than meningitis), Pseudomonas other than \nP. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (indications other than meningitis), Pseudomonas other than \nP. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (meningitis), P. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem (meningitis), P. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem-vaborbactam, \nP. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 82.0,
    "breakpoint_R": 82.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Meropenem-vaborbactam, \nP. aeruginosa",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 161.0,
    "breakpoint_R": 161.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pseudomonas aeruginosa",
    "antimicrobial": "Colistin",
    "ab": "COL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 42.0,
    "breakpoint_R": 42.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Stenotrophomonas maltophilia",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Stenotrophomonas maltophilia",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 50.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 21.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 81.0,
    "breakpoint_R": 81.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Amikacin (systemic infections)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Amikacin (infections originating from the urinary tract)",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Gentamicin (systemic infections)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Gentamicin (systemic infections)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Gentamicin (infections originating from the urinary tract)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Gentamicin (infections originating from the urinary tract)",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Tobramycin (systemic infections)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "systemic infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Tobramycin (infections originating from the urinary tract)",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Colistin",
    "ab": "COL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Acinetobacter spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Benzylpenicillin, S. aureus",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Benzylpenicillin, S. aureus",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Benzylpenicillin, S. lugdunensis",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Benzylpenicillin, S. lugdunensis",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ampicillin, S. saprophyticus",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Oxacillin (screen only), S. pseudintermedius, S. intermedius, S. schleiferi and S. coagulans",
    "ab": "OXA",
    "category": null,
    "method": "DISK",
    "disk_dose": "1",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Cefoxitin (screen only), S. aureus and coagulase-negative staphylococci except \nS. epidermidis and S. lugdunensis",
    "ab": "FOX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Cefoxitin (screen only), S. epidermidis and S. lugdunensis",
    "ab": "FOX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftaroline (indications other than pneumonia), S. aureus",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 17.0,
    "breakpoint_R": null,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftaroline (indications other than pneumonia), S. aureus",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftaroline (pneumonia), S. aureus",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mg/L",
    "indication": "pneumonia",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftaroline (pneumonia), S. aureus",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "pneumonia",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftobiprole, S. aureus",
    "ab": "BPR",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ceftobiprole, S. aureus",
    "ab": "BPR",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ciprofloxacin, S. aureus",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.0012,
    "breakpoint_R": 22.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ciprofloxacin, S. aureus",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ciprofloxacin, \nCoagulase-negative staphylococci",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.0012,
    "breakpoint_R": 22.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Ciprofloxacin, \nCoagulase-negative staphylococci",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Delafloxacin (community-acquired pneumonia), S. aureus",
    "ab": "DEL",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.016,
    "breakpoint_R": 0.016,
    "unit": "mg/L",
    "indication": "community-acquired pneumonia",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Delafloxacin (skin and skin structure infections), S. aureus",
    "ab": "DEL",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "skin and skin structure infections",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Levofloxacin, S. aureus",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Levofloxacin, S. aureus",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Levofloxacin, \nCoagulase-negative staphylococci",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Levofloxacin, \nCoagulase-negative staphylococci",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Moxifloxacin3, S. aureus",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Moxifloxacin3, S. aureus",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Moxifloxacin3, \nCoagulase-negative staphylococci",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Moxifloxacin3, \nCoagulase-negative staphylococci",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Amikacin, S. aureus",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 161.0,
    "breakpoint_R": 161.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Amikacin, S. aureus",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Amikacin, \nCoagulase-negative staphylococci",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 161.0,
    "breakpoint_R": 161.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Amikacin, \nCoagulase-negative staphylococci",
    "ab": "AMK",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Gentamicin, S. aureus",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Gentamicin, S. aureus",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Gentamicin,\nCoagulase-negative staphylococci",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Gentamicin,\nCoagulase-negative staphylococci",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tobramycin, S. aureus",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tobramycin, S. aureus",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tobramycin, \nCoagulase-negative staphylococci",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tobramycin, \nCoagulase-negative staphylococci",
    "ab": "TOB",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Dalbavancin",
    "ab": "DAL",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 0.253,
    "breakpoint_R": 0.253,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Oritavancin2, S. aureus",
    "ab": "ORI",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 0.1253,
    "breakpoint_R": 0.1253,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Teicoplanin2, S. aureus",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Teicoplanin, \nCoagulase-negative staphylococci",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Telavancin2, MRSA",
    "ab": "TEL",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 0.1253,
    "breakpoint_R": 0.1253,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Vancomycin2, S. aureus",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Vancomycin2, \nCoagulase-negative staphylococci",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Roxithromycin",
    "ab": "ROX",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Quinupristin-dalfopristin",
    "ab": "QDA",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Quinupristin-dalfopristin",
    "ab": "QDA",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Eravacycline, S. aureus",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Eravacycline, S. aureus",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "20",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.53,
    "breakpoint_R": 0.53,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tedizolid",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Tedizolid",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Daptomycin1, S. aureus",
    "ab": "DAP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Fusidic acid",
    "ab": "FUS",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Fusidic acid",
    "ab": "FUS",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Gepotidacin (uncomplicated UTI only), \nS. saprophyticus",
    "ab": "GEP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Lefamulin, S. aureus",
    "ab": "LEF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Lefamulin, S. aureus",
    "ab": "LEF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nS. saprophyticus",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 64.0,
    "breakpoint_R": 64.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nS. saprophyticus",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "100",
    "breakpoint_S": 13.0,
    "breakpoint_R": 13.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Rifampicin, S. aureus",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Rifampicin, S. aureus",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Rifampicin, Coagulase-negative staphylococci",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Rifampicin, Coagulase-negative staphylococci",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Trimethoprim (uncomplicated UTI only)",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Trimethoprim (uncomplicated UTI only)",
    "ab": "TMP",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Staphylococcus spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Ampicillin iv",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Ampicillin iv",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 10.0,
    "breakpoint_R": 10.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Amoxicillin iv",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Amoxicillin oral (uncomplicated UTI only)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Piperacillin, E. faecalis",
    "ab": "PIP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Piperacillin, E. faecalis",
    "ab": "PIP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Piperacillin-tazobactam2, E. faecalis",
    "ab": "PIP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0015,
    "breakpoint_R": 165.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Piperacillin-tazobactam2, E. faecalis",
    "ab": "PIP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Imipenem, E. faecalis",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Imipenem, E. faecalis",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Ciprofloxacin (uncomplicated UTI only)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Ciprofloxacin (uncomplicated UTI only)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Levofloxacin (uncomplicated UTI only)",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Levofloxacin (uncomplicated UTI only)",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Vancomycin, E. faecalis and E. faecium",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Vancomycin, E. faecalis and E. faecium",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Vancomycin, other enterococci",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Vancomycin, other enterococci",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Quinupristin-dalfopristin, E. faecium",
    "ab": "QDA",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Quinupristin-dalfopristin, E. faecium",
    "ab": "QDA",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Eravacycline",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Eravacycline",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "20",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.52,
    "breakpoint_R": 0.52,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Gepotidacin (uncomplicated UTI only), \nE. faecalis",
    "ab": "GEP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nE. faecalis",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 64.0,
    "breakpoint_R": 64.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Enterococcus spp.",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nE. faecalis",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "100",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Benzylpenicillin2, Streptococcus groups A, C and G",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Benzylpenicillin2, Streptococcus groups A, C and G",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Benzylpenicillin2,  \nS. agalactiae (group B streptococci)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": "group b streptococci",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Benzylpenicillin2,  \nS. agalactiae (group B streptococci)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "group b streptococci",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Delafloxacin",
    "ab": "DEL",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Dalbavancin",
    "ab": "DAL",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": null,
    "breakpoint_R": 0.1252,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Oritavancin",
    "ab": "ORI",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": null,
    "breakpoint_R": 0.252,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 13.0,
    "breakpoint_R": 13.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Roxithromycin",
    "ab": "ROX",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.1253,
    "breakpoint_R": 0.1253,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tigecycline",
    "ab": "TGC",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tedizolid",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.52,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Tedizolid",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Daptomycin",
    "ab": "DAP",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nS. agalactiae (group B streptococci)",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 64.0,
    "breakpoint_R": 64.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only), \nS. agalactiae (group B streptococci)",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "100",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus groups A,B,C,G",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Benzylpenicillin (indications other than endocarditis and meningitis)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Benzylpenicillin (endocarditis and meningitis)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ampicillin iv (indications other than endocarditis and meningitis)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ampicillin iv (indications other than endocarditis and meningitis)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 22.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ampicillin iv (endocarditis and meningitis)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Amoxicillin iv (endocarditis and meningitis)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Amoxicillin oral",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Amoxicillin-clavulanic acid oral",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.54,
    "breakpoint_R": 14.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Oxacillin (screen only)",
    "ab": "OXA",
    "category": null,
    "method": "DISK",
    "disk_dose": "1",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefaclor",
    "ab": "CEC",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefaclor",
    "ab": "CEC",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefotaxime (indications other than endocarditis and meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefotaxime (endocarditis and meningitis)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefpodoxime",
    "ab": "CPD",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ceftaroline",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ceftobiprole",
    "ab": "BPR",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ceftriaxone (indications other than endocarditis and meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ceftriaxone (endocarditis and meningitis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Cefuroxime oral",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 10.0,
    "breakpoint_R": 10.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Roxithromycin",
    "ab": "ROX",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Lefamulin",
    "ab": "LEF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Lefamulin",
    "ab": "LEF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Streptococcus pneumoniae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (screen only)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (screen only)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (indications other than endocarditis)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (indications other than endocarditis)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 21.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (endocarditis)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "endocarditis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (endocarditis)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "endocarditis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (endocarditis, in combination with other antimicrobial treatment)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mg/L",
    "indication": "endocarditis, in combination with other antimicrobial treatment",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Benzylpenicillin (endocarditis, in combination with other antimicrobial treatment)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "endocarditis, in combination with other antimicrobial treatment",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ampicillin (indications other than endocarditis)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ampicillin (indications other than endocarditis)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 21.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ampicillin iv (endocarditis)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "endocarditis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ampicillin iv (endocarditis)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "endocarditis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Amoxicillin (indications other than endocarditis)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Amoxicillin iv (endocarditis)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "endocarditis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Imipenem-relebactam",
    "ab": "IMR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Delafloxacin, S. anginosus group",
    "ab": "DEL",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Dalbavancin1, S. anginosus group",
    "ab": "DAL",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": null,
    "breakpoint_R": 0.1252,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Oritavancin1, S. anginosus group",
    "ab": "ORI",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": null,
    "breakpoint_R": 0.252,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Teicoplanin",
    "ab": "TEC",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides and lipoglycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Eravacycline",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Eravacycline",
    "ab": "ERV",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "20",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Tedizolid, S. anginosus group",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Viridans group streptococci",
    "antimicrobial": "Tedizolid, S. anginosus group",
    "ab": "TZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ampicillin (indications other than meningitis)",
    "ab": "AMP",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ampicillin (indications other than meningitis)",
    "ab": "AMP",
    "category": "Benzylpenicillin (screen only)",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": null,
    "breakpoint_R": 14.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin iv (indications other than meningitis)",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin oral",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin-clavulanic acid iv",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin-clavulanic acid iv",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin-clavulanic acid oral",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 0.0016,
    "breakpoint_R": 26.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Amoxicillin-clavulanic acid oral",
    "ab": "AMX",
    "category": "Benzylpenicillin (screen only)",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 50.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Benzylpenicillin (screen only)",
    "method": "MIC",
    "breakpoint_S": 0.257,
    "breakpoint_R": 0.257,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Benzylpenicillin (screen only)",
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefixime",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefixime",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefpodoxime",
    "ab": "CPD",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefpodoxime",
    "ab": "CPD",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftaroline",
    "ab": "CPT",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftibuten",
    "ab": "CTB",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftibuten",
    "ab": "CTB",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftolozane-tazobactam (pneumonia)",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": "pneumonia",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftolozane-tazobactam (pneumonia)",
    "ab": "C/T",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30-10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": "pneumonia",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 32.0,
    "breakpoint_R": 32.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefuroxime oral",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Cefuroxime oral",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems1,",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems1,",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems1,",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Meropenem (indications other than meningitis)",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Meropenem (meningitis)",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 32.0,
    "breakpoint_R": 32.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Nalidixic acid (screen only)",
    "ab": "NAL",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Chloramphenicol",
    "ab": "CHL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Chloramphenicol",
    "ab": "CHL",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Rifampicin (for prophylaxis only)",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "for prophylaxis only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Rifampicin (for prophylaxis only)",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": "for prophylaxis only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Haemophilus influenzae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefixime",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefixime",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 24.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 21.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefuroxime oral",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Cefuroxime oral",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Doripenem",
    "ab": "DOR",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 33.0,
    "breakpoint_R": 33.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 31.0,
    "breakpoint_R": 31.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Nalidixic acid (screen only)",
    "ab": "NAL",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Roxithromycin",
    "ab": "ROX",
    "category": "Macrolides, lincosamides and streptogramins",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Minocycline",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Moraxella catarrhalis",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Benzylpenicillin (surrogate agent)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.061,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "surrogate agent",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Cefixime",
    "ab": "CFM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Ofloxacin",
    "ab": "OFX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria gonorrhoeae",
    "antimicrobial": "Spectinomycin",
    "ab": "SPE",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 64.0,
    "breakpoint_R": 64.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Benzylpenicillin (all indications)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Ampicillin (indications other than meningitis)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Amoxicillin (indications other than meningitis)",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Cefotaxime (all indications)",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Ceftriaxone (all indications including prophylaxis)",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": "all indications including prophylaxis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Meropenem (all indications)1,",
    "ab": "MEM",
    "category": "Carbapenems1,",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Ciprofloxacin (all indications, including meningitis and prophylaxis)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.016,
    "breakpoint_R": 0.016,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Minocycline (prophylaxis only)",
    "ab": "MNO",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": "prophylaxis only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Tetracycline (screen only)",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Chloramphenicol (meningitis)",
    "ab": "CHL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Neisseria meningitidis",
    "antimicrobial": "Rifampicin (prophylaxis only)",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "prophylaxis only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": null,
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 14.0,
    "breakpoint_R": 14.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 45.0,
    "breakpoint_R": 45.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 10.0,
    "breakpoint_R": 10.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": null,
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 33.0,
    "breakpoint_R": 33.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 35.0,
    "breakpoint_R": 35.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 34.0,
    "breakpoint_R": 34.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 31.0,
    "breakpoint_R": 31.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 33.0,
    "breakpoint_R": 33.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 32.0,
    "breakpoint_R": 32.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.061,
    "breakpoint_R": 0.061,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 35.0,
    "breakpoint_R": 35.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 36.0,
    "breakpoint_R": 36.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.031,
    "breakpoint_R": 0.031,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 35.0,
    "breakpoint_R": 35.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 19.0,
    "breakpoint_R": 19.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.061,
    "breakpoint_R": 0.061,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ampicillin-sulbactam",
    "ab": "SAM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10-10",
    "breakpoint_S": 33.0,
    "breakpoint_R": 33.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.061,
    "breakpoint_R": 0.061,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 33.0,
    "breakpoint_R": 33.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Ertapenem",
    "ab": "ETP",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.031,
    "breakpoint_R": 0.031,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 39.0,
    "breakpoint_R": 39.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Antimicrobial agent",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 34.0,
    "breakpoint_R": 34.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Fidaxomicin",
    "ab": "FID",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Anaerobic bacteria",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Antimicrobial agent",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Amoxicillin oral",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Metronidazole",
    "ab": "MTZ",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 8.0,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Helicobacter pylori",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Benzylpenicillin (indications other than meningitis)",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Benzylpenicillin (indications other than meningitis)",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 13.0,
    "breakpoint_R": 13.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Ampicillin iv (all indications)",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Ampicillin iv (all indications)",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Meropenem (all indications)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Meropenem (all indications)",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Erythromycin (indications other than meningitis)",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Erythromycin (indications other than meningitis)",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": "non-meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Trimethoprim-sulfamethoxazole (all indications)",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Listeria monocytogenes",
    "antimicrobial": "Trimethoprim-sulfamethoxazole (all indications)",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": "all indications",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Nalidixic acid (screen only)",
    "ab": "NAL",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Pasteurella spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": null,
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Erythromycin, C. jejuni",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Erythromycin, C. jejuni",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Erythromycin, C. coli",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "MIC",
    "breakpoint_S": 81.0,
    "breakpoint_R": 81.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Erythromycin, C. coli",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 18.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Campylobacter jejuni/coli",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 50.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Moxifloxacin",
    "ab": "MXF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium spp.",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 50.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.0011,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Clindamycin, C. diphtheriae",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Clindamycin, C. diphtheriae",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Corynebacterium diphtheriae/ulcerans",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": null,
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 31.0,
    "breakpoint_R": 31.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Ciprofloxacin (uncomplicated UTI only)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Ciprofloxacin (uncomplicated UTI only)",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Levofloxacin (uncomplicated UTI only)",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only)",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mg/L",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Nitrofurantoin (uncomplicated UTI only)",
    "ab": "NIT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "100",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": "UTI",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aerococcus sanguinicola/urinae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Ampicillin",
    "ab": "AMP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.062,
    "breakpoint_R": 0.062,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Amoxicillin",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.1252,
    "breakpoint_R": 0.1252,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "DISK",
    "disk_dose": "2-1",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Ceftriaxone",
    "ab": "CRO",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Cefuroxime iv",
    "ab": "CXM",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.03,
    "breakpoint_R": 0.03,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.06,
    "breakpoint_R": 0.06,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Clarithromycin",
    "ab": "CLR",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Kingella kingae",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 28.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Cefepime",
    "ab": "FEP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 27.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Aztreonam",
    "ab": "ATM",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 29.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 27.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Aeromonas spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 26.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Achromobacter xylosoxidans",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Piperacillin-tazobactam",
    "ab": "TZP",
    "category": null,
    "method": "DISK",
    "disk_dose": "30-6",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Cefotaxime",
    "ab": "CTX",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Pefloxacin (screen only)",
    "ab": "PEF",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides",
    "method": "MIC",
    "breakpoint_S": 4.0,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Azithromycin",
    "ab": "AZM",
    "category": "Macrolides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 16.0,
    "breakpoint_R": 16.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Erythromycin (screen only)",
    "ab": "ERY",
    "category": "Macrolides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Vibrio spp.",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.25,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": null,
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 25.0,
    "breakpoint_R": 25.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Norfloxacin (screen only)",
    "ab": "NOR",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mm",
    "indication": "screen only",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 10.0,
    "breakpoint_R": 10.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Erythromycin",
    "ab": "ERY",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "15",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus spp.",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 22.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Benzylpenicillin",
    "ab": "PEN",
    "category": null,
    "method": "DISK",
    "disk_dose": "1 unit",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Amoxicillin iv",
    "ab": "AMX",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.1251,
    "breakpoint_R": 0.1251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.25,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "MIC",
    "breakpoint_S": 41.0,
    "breakpoint_R": 41.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Vancomycin",
    "ab": "VAN",
    "category": "Glycopeptides",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 10.0,
    "breakpoint_R": 10.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "MIC",
    "breakpoint_S": 1.0,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Clindamycin",
    "ab": "CLI",
    "category": "Macrolides and lincosamides",
    "method": "DISK",
    "disk_dose": "2",
    "breakpoint_S": 17.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.061,
    "breakpoint_R": 0.061,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 26.0,
    "breakpoint_R": 26.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Linezolid",
    "ab": "LZD",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Bacillus anthracis",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 12.0,
    "breakpoint_R": 12.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Ceftriaxone (meningitis)",
    "ab": "CRO",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Ceftriaxone (meningitis)",
    "ab": "CRO",
    "category": null,
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 30.0,
    "breakpoint_R": 30.0,
    "unit": "mm",
    "indication": "meningitis",
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Ciprofloxacin",
    "ab": "CIP",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 27.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 1.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Levofloxacin",
    "ab": "LVX",
    "category": "Fluoroquinolones",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 50.0,
    "breakpoint_R": 28.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Gentamicin",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 0.51,
    "breakpoint_R": 0.51,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Gentamicin",
    "ab": "GEN",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 23.0,
    "breakpoint_R": 23.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Streptomycin",
    "ab": "STR",
    "category": "Aminoglycosides",
    "method": "MIC",
    "breakpoint_S": 11.0,
    "breakpoint_R": 11.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Streptomycin",
    "ab": "STR",
    "category": "Aminoglycosides",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 15.0,
    "breakpoint_R": 15.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.5,
    "breakpoint_R": 0.5,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Tetracycline",
    "ab": "TCY",
    "category": "Tetracyclines",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 42.0,
    "breakpoint_R": 42.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 21.0,
    "breakpoint_R": 21.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Rifampicin",
    "ab": "RIF",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "5",
    "breakpoint_S": 20.0,
    "breakpoint_R": 20.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.125,
    "breakpoint_R": 0.125,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Brucella melitensis",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.0011,
    "breakpoint_R": 81.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Amoxicillin-clavulanic acid",
    "ab": "AMC",
    "category": null,
    "method": "DISK",
    "disk_dose": "20-10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Ceftazidime",
    "ab": "CAZ",
    "category": "Cephalosporins",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 50.0,
    "breakpoint_R": 18.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Imipenem",
    "ab": "IPM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 29.0,
    "breakpoint_R": 29.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "MIC",
    "breakpoint_S": 2.0,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Meropenem",
    "ab": "MEM",
    "category": "Carbapenems",
    "method": "DISK",
    "disk_dose": "10",
    "breakpoint_S": 24.0,
    "breakpoint_R": 24.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Doxycycline",
    "ab": "DOX",
    "category": "Tetracyclines",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 2.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Chloramphenicol",
    "ab": "CHL",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 8.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Chloramphenicol",
    "ab": "CHL",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "30",
    "breakpoint_S": 50.0,
    "breakpoint_R": 22.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "MIC",
    "breakpoint_S": 0.001,
    "breakpoint_R": 4.0,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Burkholderia pseudomallei",
    "antimicrobial": "Trimethoprim-sulfamethoxazole",
    "ab": "SXT",
    "category": "Miscellaneous agents",
    "method": "DISK",
    "disk_dose": "1.25-23.75",
    "breakpoint_S": 50.0,
    "breakpoint_R": 17.0,
    "unit": "mm",
    "indication": null,
    "source": "clinical"
  },
  {
    "guideline": "EUCAST 2026",
    "organism_group": "Mycobacterium tuberculosis",
    "antimicrobial": "Bedaquiline",
    "ab": "BED",
    "category": null,
    "method": "MIC",
    "breakpoint_S": 0.251,
    "breakpoint_R": 0.251,
    "unit": "mg/L",
    "indication": null,
    "source": "clinical"
  }
]